THROMBOLYTIC SCIENCE INTERNATIONAL
Thrombolytic Science is focused on developing a proprietary product, M5, a mutant of pro-urokinase (proUK). M5 is a thrombolytic that follows a different paradigm than tPA, has superior efficacy and is accompanied by little bleeding risk.
THROMBOLYTIC SCIENCE INTERNATIONAL
Social Links:
Industry:
Biotechnology Therapeutics
Founded:
2004-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.tsillc.net
Total Employee:
1+
Status:
Active
Contact:
617-661-1103
Total Funding:
7.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Microsoft Azure DNS Wix
Similar Organizations
Akarna Therapeutics
At Akarna, our mission is to develop best-in-class treatments for NASH and other chronic liver diseases
Galenea
Galenea is engaged in developing therapeutics for central nervous system diseases.
Current Employees Featured
Founder
Official Site Inspections
http://www.tsillc.net
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
